In practice, this doesnt slow down access for most patients
This new indication, based on the SOUL data, marks even further advancement and showcases the versatility of semaglutide while expanding options for millions of people. As the only FDA-approved GLP-1 therapy in a pill, now recognized for its proven cardiovascular benefits, a new benchmark has been set for future oral innovations, added Dave Moore, executive vice president of US Operations for Novo Nordisk
Understanding semaglutide-related fatigue and whether tirzepatide causes tiredness helps people plan their titration around work and life demands
Science , 350 (6265), 12081213
Semaglutide 5mg/mL + Gylcine 5mg/mL + Cyanocobalamin 1mg/mL Subcutaneous Injectable
Your healthcare provider will determine the lowest effective dosage for you depending on your BMI majorly